# Compassionate Use of Omegaven in Children

> **NCT02370251** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Oklahoma** · enrollment: 63 (actual)

## Conditions studied

- Total Parenteral Nutrition-induced Cholestasis
- Cholestasis
- Short Bowel Syndrome
- Gastroschisis
- Intestinal Atresia
- Infant, Premature, Diseases
- Cholestasis of Parenteral Nutrition

## Interventions

- **DRUG:** Omegaven

## Key facts

- **NCT ID:** NCT02370251
- **Lead sponsor:** University of Oklahoma
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2018-09-27
- **Final completion:** 2019-09-27
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2019-11-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02370251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02370251, "Compassionate Use of Omegaven in Children". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02370251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*